These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12573190)

  • 1. Clinical trials of vitamin E in coronary artery disease: is it time to reconsider the low-density lipoprotein oxidation hypothesis?
    Heinecke JW
    Curr Atheroscler Rep; 2003 Mar; 5(2):83-7. PubMed ID: 12573190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis.
    Heinecke JW
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1261-4. PubMed ID: 11498450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of increasing doses of alpha-tocopherol in providing protection of low-density lipoprotein from oxidation.
    Fuller CJ; Huet BA; Jialal I
    Am J Cardiol; 1998 Jan; 81(2):231-3. PubMed ID: 9591910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin E and heart disease: basic science to clinical intervention trials.
    Pryor WA
    Free Radic Biol Med; 2000 Jan; 28(1):141-64. PubMed ID: 10656300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E: murine studies versus clinical trials.
    Praticò D
    Ital Heart J; 2001 Dec; 2(12):878-81. PubMed ID: 11838331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitamin E and coronary heart disease--why the lack of effect in large clinical trials?].
    Andersen JR
    Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1932-6. PubMed ID: 11488186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E in cardiovascular disease: has the die been cast?
    Yusoff K
    Asia Pac J Clin Nutr; 2002; 11 Suppl 7():S443-7. PubMed ID: 12492632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized LDL and antioxidants.
    Jialal I; Fuller CJ
    Clin Cardiol; 1993 Apr; 16(4 Suppl 1):I6-9. PubMed ID: 8472396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis.
    Jialal I; Fuller CJ
    Can J Cardiol; 1995 Oct; 11 Suppl G():97G-103G. PubMed ID: 7585302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of dietary vitamin E on in vivo and in vitro parameters of lipid peroxidation in the rabbit.
    Wiseman SA; Van den Boom MA; De Fouw NJ; Wassink MG; Op den Kamp JA; Tijburg LB
    Free Radic Biol Med; 1995 Nov; 19(5):617-26. PubMed ID: 8529921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men.
    Porkkala-Sarataho E; Nyyssönen K; Salonen JT
    Atherosclerosis; 1996 Jul; 124(1):83-94. PubMed ID: 8800496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL oxidation: therapeutic perspectives.
    Heller FR; Descamps O; Hondekijn JC
    Atherosclerosis; 1998 Apr; 137 Suppl():S25-31. PubMed ID: 9694538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What dose of vitamin E is required to reduce susceptibility of LDL to oxidation?
    Simons LA; Von Konigsmark M; Balasubramaniam S
    Aust N Z J Med; 1996 Aug; 26(4):496-503. PubMed ID: 8873932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis.
    Thomas SR; Stocker R
    Free Radic Biol Med; 2000 Jun; 28(12):1795-805. PubMed ID: 10946221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits.
    Tijburg LB; Wiseman SA; Meijer GW; Weststrate JA
    Atherosclerosis; 1997 Nov; 135(1):37-47. PubMed ID: 9395271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.
    Walters-Laporte E; Furman C; Fouquet S; Martin-Nizard F; Lestavel S; Gozzo A; Lesieur D; Fruchart JC; Duriez P; Teissier E
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue.
    Iuliano L; Pedersen JZ; Camastra C; Bello V; Ceccarelli S; Violi F
    Free Radic Biol Med; 1999 Apr; 26(7-8):858-68. PubMed ID: 10232829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of selective low-density lipoprotein apheresis on plasma lipoperoxides and antioxidant vitamins in familial hypercholesterolemic patients.
    Baricchi R; Pizzala R; Cacciavillani G; Rivasi P; Tomasi A
    Ther Apher; 1998 Aug; 2(3):218-23. PubMed ID: 10227773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update: vitamin E supplementation and heart disease.
    Blumberg JB
    Nutr Clin Care; 2002; 5(2):50-5. PubMed ID: 12134710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of in-vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification.
    Suzukawa M; Ishikawa T; Yoshida H; Nakamura H
    J Am Coll Nutr; 1995 Feb; 14(1):46-52. PubMed ID: 7706609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.